Device Trial Radar · NCT03226808
Vivacit-E Post-market Follow-up Study
Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
245
Actual
Start
Oct 1, 2013
Primary completion
Apr 14, 2026
Study completion Apr 14, 2026
Sponsor
- Lead sponsor
- Zimmer BiometPublic (ZBH)
- Sponsor type
- Industry
- First posted
- Jul 24, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners. This will be done by analysis of polyethylene wear, validated outcome measurement tools, radiographs, and reported adverse events data.
Conditions
- Osteoarthritis
- Avascular Necrosis of Bone of Hip
- Post-traumatic; Arthrosis
- Congenital Hip Dysplasia
Interventions
Vivacit-E LinerDevice
All subjects enrolled will receive the Vivacit-E liner.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival of the study device; whether or not it is still implanted in the subjectTime frame: 10 years
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Denver Hip and Knee, Inc.
Parker, Colorado
Department of Orthopaedics University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
OrthoCarolina Research Institute
Charlotte, North Carolina
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.